Roivant Sciences Unit Kinevant Sciences' Lung Disease Drug Fails in Mid-Stage Study

Roivant Sciences子公司Kinevant Sciences的肺部疾病药物在中期研究中失败

WSJ · 12/03 20:35

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.